Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Patient Preference and Adherence
|
April 28, 2021
Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic Review
Paul M Overton, Natalie Shalet, Fabian Somers, et al.
Pharmaceutical Medicine
|
January 18, 2023
Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions
Stuart D Faulkner, Fabian Somers, Mathieu Boudes, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
August 3, 2006
Compatibility of insulin over 24 hours in standard and bicarbonate-based peritoneal dialysis solutions contained in bags made of different materials
Markus Voges, Jose C Divino-Filho, Dirk Faict, et al.
Journal of Medicinal Chemistry
|
March 23, 2013
1,4,2-Benzo/pyridodithiazine 1,1-dioxides structurally related to the ATP-sensitive potassium channel openers 1,2,4-Benzo/pyridothiadiazine 1,1-dioxides exert a myorelaxant activity linked to a distinct mechanism of action
Bernard Pirotte, Pascal de Tullio, Xavier Florence, et al.
Biological Chemistry
|
January 18, 2003
2-alkyl-3-Alkylamino-2H-Benzo- and pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers?
Raogo Ouedraogo, Bénédicte Becker, Stéphane Boverie, et al.
Journal of Medicinal Chemistry
|
November 15, 2011
Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stability
Pascal de Tullio, Anne-Catherine Servais, Marianne Fillet, et al.
Journal of Medicinal Chemistry
|
November 19, 2009
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity
Bernard Pirotte, Pascal de Tullio, Quynh-Anh Nguyen, et al.
Journal of Medicinal Chemistry
|
May 13, 2005
Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides
Stéphane Boverie, Marie-Hélène Antoine, Fabian Somers, et al.
Journal of Medicinal Chemistry
|
July 11, 2003
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides
Pascal de Tullio, Bénédicte Becker, Stéphane Boverie, et al.
Therapeutic Innovation & Regulatory Science
|
July 4, 2020
Amplifying the Voice of the Patient in Clinical Research: Development of Toolkits for Use in Designing and Conducting Patient-Centered Clinical Studies
, Mary Elmer, Cathy Florek, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Patient Preference and Adherence
|
April 28, 2021
Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic Review
Paul M Overton, Natalie Shalet, Fabian Somers, et al.
Pharmaceutical Medicine
|
January 18, 2023
Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions
Stuart D Faulkner, Fabian Somers, Mathieu Boudes, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
August 3, 2006
Compatibility of insulin over 24 hours in standard and bicarbonate-based peritoneal dialysis solutions contained in bags made of different materials
Markus Voges, Jose C Divino-Filho, Dirk Faict, et al.
Journal of Medicinal Chemistry
|
March 23, 2013
1,4,2-Benzo/pyridodithiazine 1,1-dioxides structurally related to the ATP-sensitive potassium channel openers 1,2,4-Benzo/pyridothiadiazine 1,1-dioxides exert a myorelaxant activity linked to a distinct mechanism of action
Bernard Pirotte, Pascal de Tullio, Xavier Florence, et al.
Biological Chemistry
|
January 18, 2003
2-alkyl-3-Alkylamino-2H-Benzo- and pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers?
Raogo Ouedraogo, Bénédicte Becker, Stéphane Boverie, et al.
Journal of Medicinal Chemistry
|
November 15, 2011
Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stability
Pascal de Tullio, Anne-Catherine Servais, Marianne Fillet, et al.
Journal of Medicinal Chemistry
|
November 19, 2009
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity
Bernard Pirotte, Pascal de Tullio, Quynh-Anh Nguyen, et al.
Journal of Medicinal Chemistry
|
May 13, 2005
Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides
Stéphane Boverie, Marie-Hélène Antoine, Fabian Somers, et al.
Journal of Medicinal Chemistry
|
July 11, 2003
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides
Pascal de Tullio, Bénédicte Becker, Stéphane Boverie, et al.
Therapeutic Innovation & Regulatory Science
|
July 4, 2020
Amplifying the Voice of the Patient in Clinical Research: Development of Toolkits for Use in Designing and Conducting Patient-Centered Clinical Studies
, Mary Elmer, Cathy Florek, et al.
Page
of 2